We consider a profiling experiment on a publicly available prostate cancer dataset: the task is to select a list of predictive biomarkers and a classifier to predictively discriminate prostate cancer patients carrying the TMPRSS2-ER gene fusion. This evidence concerns the gene TMPRSS2 and prostate cancer.